Pyxis Oncology Inc is trading at $2.15 (5.9% up) today, extending a strong multi-day move following upbeat Q1 2026 results and clinical progress commentary shared earlier this month.
- The stock has seen significant momentum recently, climbing from approximately $1.67 on June 10 to its current level above $2.00.
- No new company-specific filings or press releases have been issued today, June 22, suggesting the move is a continuation of recent positive sentiment.
- The price action reflects a combination of clinical pipeline optimism and the typical volatility associated with small-cap biotechnology names.